Wales Heart Research Institute, Cardiff University
Cardiff, CF14 4XN, United Kingdom
NCT Number: NCT01295047
The investigators are looking at the different impacts of atenolol, verapamil and perindopril on large artery and lv function in marfan syndrome. It is a double-blind, randomised cross-over trial.
Looking for future studies?
Notify Me16 year–60 year
All sexes
Interventional
Phase 4
Cardiff, CF14 4XN, United Kingdom
The investigators recruited 21 patients with confirmed diagnosis of Marfan syndrome from two centres. The investigators performed radial artery applanation tonometry and pulse wave analysis to derive central aortic pressure and haemodynamic indexes pre-and post administering Atenolol 75mg, Perindopril 4mg and Verapamil 240mgs each for four weeks with a two week wash-out between medications. All patients underwent detailed functional and anatomical echocardiographic assessments at each visit.
Inclusion criteria
were ages 16-60 years with no treatment or β-blocker or other monotherapy only for Marfan syndrome. Patients with previous aortic dissection or aortic surgery, severe valvular regurgitation, aortic diameter at the sinotubular junction ≥ 5.0cm, contraindications to specific drug treatment, e.g. asthma and β-blocker, or those who were pregnant or at risk of pregnancy were excluded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
240 MG SR
4 MG
Time frame: 18 weeks
CENTRAL ARTERIAL PRESSURE MEASURED BY APPLANATION TONOMETRY
Time frame: 18 WEEKS
MEASURED BY ECHO AND BY PULSE WAVE VELOCITY/ANALYSIS BY APPLANATION TONOMETRY
Time frame: 18 WEEKS
GLOBAL AND REGIONAL MARKERS BY ECHO
Cardiff University
Other
Effects of Atenolol, Perindopril and Verapamil on Haemodynamic and Vascular Function in Marfan Syndrome - A Randomised Double-Blind Crossover Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04776681
Abnormalities, Multiple, Bone Diseases
London, United Kingdom
View Trial DetailsNCT03236571
Abnormalities, Multiple, Bone Diseases
Toulouse, Midi-Pyrénées, France
View Trial DetailsNCT07360704
Abnormalities, Multiple, Aneurysm
Pavia, Lombardy, Italy
View Trial DetailsNCT05123339
Abnormalities, Multiple, Arachnodactyly
Paris, IDF, France
View Trial Details